Advertisement

© 2015

Small Molecule Therapeutics for Schizophrenia

  • Sylvain Celanire
  • Sonia Poli

Benefits

  • Overview chapters introduce the newcomer to the topic covered

  • Series covers hot topics of frontier research summarized by reputed scientists in the field

  • Volumes are useful and of relevance for a long period of time

Book

Part of the Topics in Medicinal Chemistry book series (TMC, volume 13)

Table of contents

  1. Front Matter
    Pages i-vii
  2. Bart A. Ellenbroek, Andrea M. Cesura
    Pages 1-49
  3. Roderick A. Porter, Lee A. Dawson
    Pages 51-99
  4. José M. Cid, Andrés A. Trabanco, Hilde Lavreysen
    Pages 101-142
  5. Theresa Williams, Marlene A. Jacobson, Mikhail Kalinichev, Jean-Philippe Rocher
    Pages 143-182
  6. Takaaki Sumiyoshi, Takeshi Enomoto
    Pages 183-211
  7. Anatoly Mazurov, Daniel Yohannes
    Pages 213-253
  8. Jamison B. Tuttle, Bethany L. Kormos
    Pages 255-316
  9. Back Matter
    Pages 317-323

About this book

Introduction

The topic-related series Topics in Medicinal Chemistry covers all relevant aspects of drug research, e.g. pathobiochemistry of diseases, identification and validation of (emerging) drug targets, structural biology, drug ability of targets, drug design approaches, chemogenomics, synthetic chemistry including combinatorial methods, bioorganic chemistry, natural compounds, high-throughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. Medicinal chemistry is both science and art. The science of medicinal chemistry offers mankind one of its best hopes for improving the quality of life. The art of medicinal chemistry continues to challenge its practitioners with the need for both intuition and experience to discover new drugs. Hence sharing the experience of drug research is uniquely beneficial to the field of medicinal chemistry. Drug research requires interdisciplinary team-work at the interface between chemistry, biology and medicine.

Keywords

5HT Receptor Ligands DA Receptor Ligands GLYT1 Inhibitors PDE10/PDE9 Inhibitors mACh Activators mGlu2 Activators mGlu5 Positive Allosteric Modulators nACh Activators

Editors and affiliations

  • Sylvain Celanire
    • 1
  • Sonia Poli
    • 2
  1. 1.ReignerFrance
  2. 2.Addex TherapeuticsGenevaSwitzerland

Bibliographic information

  • Book Title Small Molecule Therapeutics for Schizophrenia
  • Editors Sylvain Celanire
    Sonia Poli
  • Series Title Topics in Medicinal Chemistry
  • Series Abbreviated Title Topics Medicinal Chemistry
  • DOI https://doi.org/10.1007/978-3-319-11502-3
  • Copyright Information Springer International Publishing Switzerland 2015
  • Publisher Name Springer, Cham
  • eBook Packages Chemistry and Materials Science Chemistry and Material Science (R0)
  • Hardcover ISBN 978-3-319-11501-6
  • Softcover ISBN 978-3-319-37894-7
  • eBook ISBN 978-3-319-11502-3
  • Series ISSN 1862-2461
  • Series E-ISSN 1862-247X
  • Edition Number 1
  • Number of Pages VII, 323
  • Number of Illustrations 162 b/w illustrations, 23 illustrations in colour
  • Topics Medicinal Chemistry
    Psychopharmacology
    Neurosciences
  • Buy this book on publisher's site
Industry Sectors
Biotechnology
Chemical Manufacturing
Pharma

Reviews

From the book reviews:

“The target audience … is primarily researchers in psychopharmacology involved in drug development. … Each chapter concludes with citations of the pertinent scientific literature. This book covering small molecular therapeutics for schizophrenia would be a useful review for researchers studying this area.” (Michael Joel Schrift, Doody’s Book Reviews, March, 2015)